Form 4: Vita Coco Executive Chairman Michael Kirban Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Michael Kirban, Executive Chairman of Vita Coco Company, Inc., sold 34,000 shares of common stock on May 20 and 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Kirban, the Executive Chairman of Vita Coco Company, Inc., reported the sale of company stock.
- On May 20, 2025, he sold 20,000 shares of common stock at a weighted average price of $37.067.
- On May 21, 2025, he sold 14,000 shares of common stock at a weighted average price of $37.033.
- The sales were executed under a Rule 10b5-1 trading plan.
- Following these transactions, Kirban directly owns 127,629 shares and indirectly owns 1,629,049 shares through the M. Kirban 2010 Trust and 615,681 shares through the Michael Kirban Revocable Trust.
- Kirban also holds multiple non-qualified stock options with varying exercise prices and vesting schedules.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports stock sales under a pre-arranged plan, which doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Insider selling is a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on current, non-public information. Investors often monitor insider transactions for signals about a company's prospects, but pre-planned sales are generally viewed as less informative.
Comparison to Industry Standards
- Comparing the stock option exercise prices and vesting schedules to those of executives at similar beverage companies (e.g., Keurig Dr Pepper, National Beverage Corp.) would provide context on the competitiveness of Vita Coco's compensation structure.
- The use of 10b5-1 trading plans is a standard practice among public company executives to avoid accusations of insider trading; many companies such as Coca-Cola and PepsiCo have executives using similar plans.
Stakeholder Impact
- The stock sales could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider information.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/16/2029 | Expiration date for Non-Qualified Stock Option (right to buy) at $10.178 |
| 01/11/2031 | Expiration date for Non-Qualified Stock Option (right to buy) at $10.178 |
| 10/21/2031 | Expiration date for Non-Qualified Stock Option (right to buy) at $15 |
| 03/10/2033 | Expiration date for Non-Qualified Stock Option (right to buy) at $16.91 |
| 03/04/2034 | Expiration date for Non-Qualified Stock Option (right to buy) at $26.18 |
| 03/03/2035 | Expiration date for Non-Qualified Stock Option (right to buy) at $32.78 |
| 05/20/2025 | Date of common stock sale of 20,000 shares |
| 05/21/2025 | Date of common stock sale of 14,000 shares |
| 05/22/2025 | Date of Form 4 filing |
Keywords
Vita Coco, COCO, Michael Kirban, Stock Sale, Form 4, Rule 10b5-1, Executive Chairman, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.